Table 4.
Laboratory findings of patients with ROHHADNET syndrome (IPD).
| Laboratory findings | Total number of patients (n=48) |
|---|---|
| Number of patients (%) | |
| ABGA | |
| Hypoxemia† | 13/13(100%) |
| Hypercapnia‡ | 14/15 (93.3%) |
| Normal | 0/15 (0%) |
| No information | 34/48 (70.8%) |
| Dysnatremia | |
| Hypernatremia | 25/31 (80.6%) |
| Hyponatremia | 5/31 (16.1%) |
| Normal | 2/31 (6.5%) |
| No information | 17/48(35.4%) |
| Prolactin | |
| Hyperprolactinemia | 27/28 (96.4%) |
| Normal | 1/28 (3.6%) |
| No information | 19/48 (39.6%) |
| Thyroid dysfunction | |
| Hypothyroidism | 18/30 (60.0%) |
| Normal | 12/30 (40.0%) |
| No information | 17/48 (35.4%) |
| IGF-1 level | |
| Low | 12/16 (75.0%) |
| Normal | 4/16 (25.0%) |
| No information | 31/48 (64.6%) |
ABGA: Arterial blood gas analysis, IGF-1: Insulin-like growth factor-1.
†Hypoxemia is defined in terms of reduced partial pressure of oxygen below 80 mmHg or decreased oxygen saturation less than 90%.
‡Hypercapnia is defined in terms of elevated carbon dioxide above 45 mmHg.